HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Hasegawa Selected Research

Cacodylic Acid (Cacodylate)

9/2001Oral exposure of dimethylarsinic acid, a main metabolite of inorganic arsenics, in mice leads to an increase in 8-Oxo-2'-deoxyguanosine level, specifically in the target organs for arsenic carcinogenesis.
5/2001Oral administration of dimethylarsinic acid, a main metabolite of inorganic arsenic, in mice promotes skin tumorigenesis initiated by dimethylbenz(a)anthracene with or without ultraviolet B as a promoter.
10/200072-kDa stress protein (hsp72) induced by administration of dimethylarsinic acid to mice accumulates in alveolar flat cells of lung, a target organ for arsenic carcinogenesis.
4/2000The role of orally administered dimethylarsinic acid, a main metabolite of inorganic arsenics, in the promotion and progression of UVB-induced skin tumorigenesis in hairless mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A Hasegawa Research Topics

Disease

14Neoplasms (Cancer)
01/2020 - 04/2000
5Infections
05/2013 - 01/2000
5Infertility (Sterility)
12/2009 - 07/2000
4Chronic Kidney Failure (Chronic Renal Failure)
05/2005 - 01/2004
4Carcinogenesis
09/2001 - 04/2000
4Tinea (Ringworm)
09/2001 - 01/2000
3Inflammation (Inflammations)
04/2009 - 01/2000
3Lymphoma (Lymphomas)
12/2001 - 09/2000
3Atopic Dermatitis (Atopic Eczema)
09/2000 - 02/2000
2Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
06/2015 - 10/2000
2Hypersensitivity (Allergy)
08/2014 - 02/2000
2Prostatic Neoplasms (Prostate Cancer)
02/2011 - 12/2010
2Hypotension (Low Blood Pressure)
10/2006 - 09/2000
2Carcinoma (Carcinomatosis)
10/2006 - 10/2000
2Leukemia
05/2004 - 05/2001
2Pneumonia (Pneumonitis)
01/2004 - 03/2001
2Heart Failure
06/2003 - 07/2000
2T-Cell Leukemia (Leukemia, T Cell)
12/2001 - 10/2000
2Pathologic Constriction (Stenosis)
11/2001 - 05/2001
2Aortic Dissection
10/2000 - 03/2000
2Coronary Disease (Coronary Heart Disease)
10/2000 - 06/2000
2Herpes Zoster
07/2000 - 07/2000
1Dermatitis Herpetiformis (Disease, Duhring's)
01/2022
1Erythema elevatum diutinum
06/2021
1Stevens-Johnson Syndrome (Lyell's Syndrome)
02/2021
1Drug Hypersensitivity Syndrome
08/2014
1Osteoarthritis
01/2014
1Essential Hypertension
01/2013
1Thrombotic Thrombocytopenic Purpura
08/2012
1Hemostatic Disorders
08/2012
1Glycogen Storage Disease Type II (Pompe's Disease)
07/2012
1Inborn Genetic Diseases (Disease, Hereditary)
07/2012
1Myocardial Infarction
10/2011
1Primary Ovarian Insufficiency
12/2009
1Neuromyelitis Optica (Devic's Disease)
11/2009
1Myelitis
11/2009
1Multiple Sclerosis
11/2009
1Optic Neuritis (Retrobulbar Neuritis)
11/2009

Drug/Important Bio-Agent (IBA)

10AntigensIBA
05/2013 - 01/2000
4Proteins (Proteins, Gene)FDA Link
11/2009 - 07/2000
4CytokinesIBA
11/2009 - 05/2001
4AntibodiesIBA
10/2009 - 11/2000
4Peptides (Polypeptides)IBA
12/2001 - 01/2000
4ArsenicIBA
09/2001 - 04/2000
4Cacodylic Acid (Cacodylate)IBA
09/2001 - 04/2000
4AllergensIBA
01/2001 - 02/2000
4Immunoglobulin E (IgE)IBA
11/2000 - 02/2000
3Biomarkers (Surrogate Marker)IBA
07/2012 - 01/2000
3InterleukinsIBA
11/2009 - 05/2001
3EpitopesIBA
12/2001 - 07/2000
3DNA (Deoxyribonucleic Acid)IBA
03/2001 - 10/2000
2Interleukin-8 (Interleukin 8)IBA
06/2021 - 01/2003
2Viral RNAIBA
06/2015 - 12/2000
2Biological ProductsIBA
07/2012 - 04/2000
2Propofol (Diprivan)FDA LinkGeneric
10/2006 - 09/2000
2LDL Lipoproteins (beta Lipoproteins)IBA
11/2003 - 06/2000
2thiazole orangeIBA
04/2003 - 01/2002
2Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
01/2003 - 05/2001
2EnzymesIBA
01/2003 - 06/2000
2VaccinesIBA
12/2001 - 07/2000
2Chitin SynthaseIBA
08/2001 - 01/2000
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2001 - 05/2001
2Myosin Heavy Chains (Myosin Heavy Chain)IBA
10/2000 - 03/2000
2Prednisolone (Predate)FDA LinkGeneric
10/2000 - 08/2000
2KetamineFDA LinkGeneric
10/2000 - 09/2000
2oxidized low density lipoproteinIBA
10/2000 - 06/2000
2B-Lymphocyte Epitopes (B-Cell Epitope)IBA
07/2000 - 01/2000
2Glycoproteins (Glycoprotein)IBA
07/2000 - 01/2000
2T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
07/2000 - 01/2000
1Contrast MediaIBA
01/2022
1IodineIBA
01/2022
1Immune Checkpoint InhibitorsIBA
02/2021
1Protein Kinases (Protein Kinase)IBA
06/2015
1Double-Stranded RNA (RNA, Double Stranded)IBA
06/2015
1Chemokine CCL17IBA
08/2014
1Pharmaceutical PreparationsIBA
08/2014
1Transcription Factors (Transcription Factor)IBA
01/2014
1Celiprolol (ST1396)IBA
01/2013
1Uric Acid (Urate)IBA
01/2013
1thiamine triphosphorate (TTP)IBA
08/2012
1alpha-Glucosidases (Acid Maltase)IBA
07/2012
1AcidsIBA
07/2012
1HSP47 Heat-Shock Proteins (Heat Shock Protein 47)IBA
10/2011
1Antisense OligonucleotidesIBA
10/2011
1ChromatinIBA
02/2011
1Androgen Receptors (Androgen Receptor)IBA
02/2011
1AndrogensIBA
12/2010
1RNA (Ribonucleic Acid)IBA
12/2010
1MicroRNAs (MicroRNA)IBA
12/2010
1Interleukin-6 (Interleukin 6)IBA
11/2009
1Immunoglobulin G (IgG)IBA
11/2009
1AutoantibodiesIBA
11/2009
1Aquaporins (Water Channels)IBA
11/2009

Therapy/Procedure

7Transplantation
05/2005 - 02/2000
3Therapeutics
12/2009 - 10/2000
3Kidney Transplantation
05/2005 - 03/2001
3Oral Administration
09/2001 - 10/2000
1Re-Irradiation
01/2020
1Retreatment
01/2020
1Heavy Ion Radiotherapy
01/2020